The mechanisms by which the p53 response is triggered following exposure to DNA-damaging agents have not yet been clearly elucidated. We and others have previously suggested that blockage of RNA polymerase II may be the trigger for induction of the p53 response following exposure to ultraviolet light. Here we report on the correlation between inhibition of mRNA synthesis and the induction of p53, p21 WAF1 and apoptosis in diploid human ®broblasts treated with either UV light, cisplatin or the RNA synthesis inhibitors actinomycin D, DRB, H7 and a-amanitin. Exposure to ionizing radiation or the proteasome inhibitor LLnL, however, induced p53 and p21 WAF1 without aecting mRNA synthesis. Importantly, induction of p53 by the RNA synthesis or proteasome inhibitors did not correlate with the induction of DNA strand breaks. Furthermore, cisplatin-induced accumulation of active p53 in repair-de®cient XP-A cells occurred despite the lack of DNA strand break induction. Our results suggest that the induction of the p53 response by certain toxic agents is not triggered by DNA strand breaks but rather, may be linked to inhibition of mRNA synthesis either directly by the poisoning of RNA polymerase II or indirectly by the induction of elongation-blocking DNA lesions.
Introduction
Great advances have been made in the elucidation of the mechanisms of action of the p53 tumor suppressor protein following activation by DNA-damaging agents (Agarwal et al., 1998; Cox and Lane, 1995; Harris, 1996; Ko and Prives, 1996; Levine, 1997) . Wild-type p53 has been shown to stimulate nucleotide excision repair (Ford and Hanawalt, 1995; McKay et al., 1997; Smith et al., 1995) , mediate cell cycle arrest (Kastan et al., 1991) and facilitate apoptosis following induction of DNA damage (Clarke et al., 1993; Lowe et al., 1993) . However, the upstream mechanisms linking stress-induced signals to the induction of the p53 response are still poorly understood (Kastan, 1996) .
It has been suggested that DNA strand breaks are the DNA template alterations that trigger the p53-dependent DNA damage response pathway (Nelson and Kastan, 1994; Tishler et al., 1993) . However, in addition to DNA-damaging agents, p53 has been shown to be activated by other cellular stresses such as hypoxia (Graeber et al., 1994) , heat shock (Graeber et al., 1994; Matsumoto et al., 1994) , cold shock (Ohnishi et al., 1998) , media depletion (Zhan et al., 1993) , microtuble-active drugs (Blagosklonny et al., 1995; Mukhopadhyay and Roth, 1997; Tishler et al., 1995) , antioxidants (Liu et al., 1998; Plaumann et al., 1996) , thymidine dinucleotides (Eller et al., 1997) or perturbations of nucleotide pools (Linke et al., 1996) . It is thought that accumulation of p53 proteins as well as the activation of the sequence-speci®c DNA-binding activity of p53 are required to fully induce the p53 response (Hupp et al., 1992) . Accumulation of p53 is primarily accomplished by stabilization of the protein itself (Fritsche et al., 1993; Maltzman and Czyzyk, 1984) although, increased translation of p53 mRNAs may also be important for p53 accumulation (Fu et al., 1996; Liu et al., 1998) . The active form of the p53 protein binds DNA as a tetramer in a sequencedependent manner and transactivates target genes (Farmer et al., 1992; Zambetti et al., 1992) while concurrently reducing transcription of other genes (Ginsberg et al., 1991) .
We and others recently proposed that blockage of RNA polymerase may be the trigger for p53 accumulation and activation (Dumaz et al., 1997; Ljungman and Zhang, 1996; McKay et al., 1998; Yamaizumi and Sugano, 1994) and for the induction of apoptosis following exposure to UV light (Ljungman and Zhang, 1996; McKay et al., 1998) . This was deduced from the ®ndings that cells defective in the removal of UV-induced DNA lesions from the transcribed strand of active genes, such as cells from patients with the DNA repair syndrome xeroderma pigmentosum complementation group A (XP-A) and Cockayne's syndrome (CS), induced accumulation of active p53 and triggered cells to undergo apoptosis at signi®cantly lower doses than normal cells. Furthermore, xeroderma pigmentosum cells from complementation group C (XP-C) which are only capable of removing UV-induced lesions from the transcribed strand, were as resistant as normal cells to the induction of p53 and apoptosis. Thus, by exclusively removing lesions from the transcribed strand, XP-C cells eectively remove the signals that lead to p53 accumulation following UV-irradiation. Since UVinduced DNA lesions in the transcribed strand block elongation of RNA polymerase II (Donahue et al., 1994; Sauerbier and Hercules, 1978; Selby and Sancar, 1990) , our results suggested that blockage of RNA polymerase II elongation may be the trigger of the p53 response following exposure to UV light.
To explore whether blockage of RNA polymerase II may be sucient and possibly a common mechanism by which p53-inducing agents trigger p53, we investigated the dose response for both inhibition of mRNA synthesis and accumulation of p53 and the p53 regulated protein p21 WAF1 in human ®broblasts treated with a variety of agents. It was found that induction of p53 correlated with inhibition of mRNA synthesis, but not with induction of DNA strand breaks, in cells treated with UV light, cisplatin, actinomycin D, DRB, H7 and a-amanitin. However, mRNA synthesis was not signi®cantly inhibited by the DNA strand-breaking agent ionizing radiation or the proteasome/calpain I inhibitor LLnL although these agents caused cellular accumulation of both p53 and p21
WAF1
. Thus, we suggest that multiple pathways exist through which dierent agents may trigger the p53 response.
Results
Induction of p53 by UV light and cisplatin, but not by ionizing radiation, correlates with inhibition of mRNA synthesis UV light (254 nm) induces primarily pyrimidine dimers and 6-4 photoproducts in DNA which eciently block the progression of RNA polymerases (Donahue et al., 1994; Sauerbier and Hercules, 1978; Selby and Sancar, 1990) . Cells lacking pro®cient repair of the transcribed strand of active genes have been found to induce accumulation of p53, p21 WAF1 and Bax, and trigger cells to undergo apoptosis at signi®cantly lower doses than cells with pro®cient repair of transcribed strands (Ljungman and Zhang, 1996; McKay et al., 1998) . Thus, lesions formed in the transcribed strand of active genes appear to be responsible for the accumulation and activation of p53 as well as for the induction of apoptosis following UV-irradiation. In this study, we further investigated the correlation between the eect of UV light (254 nm), cisplatin and ionizing radiation on mRNA synthesis and the induction of p53 and p21 WAF1 accumulation in human ®broblasts. It was found that inhibition of mRNA synthesis by UV light was dose dependent (Figure 1a ). Five hours following exposure to 10 J/m 2 , full length mRNA synthesis was suppressed by about 50%. The dose response for mRNA synthesis inhibition was found to correlate with the dose response of p53 and p21 WAF1 protein accumulation at 24 h following irradiation. It could be noted that despite the strong inhibition of total mRNA synthesis at 5 h following irradiation with 20 J/m 2 , no impairment of p21 WAF1 expression was seen at 24 h. This may be a consequence of both the small target size of the p21 WAF1 gene for UV inactivation and the ecient repair of the transcribed strand of the p21 WAF1 gene within 24 h (McKay et al., 1998) . We next treated cells with the chemotherapeutic drug cisplatin. The major type of DNA lesion induced by cisplatin is the intrastrand cross-link with the G 6 G intrastrand cross-link being the predominant lesion (Eastman, 1986) . These intrastrand DNA cross-links are ecient blocks to transcript elongation both in vitro (Corda et al., 1993) and in vivo (Mello et al., 1995) . Here we show that cisplatin caused a dosedependent inhibition of mRNA synthesis in human ®broblasts (Figure 1b) . Five hours after adding cisplatin to concentrations of 25 or 50 mM, mRNA synthesis was reduced to 75 and 65% of untreated control cells, respectively. Twenty-four hours of incubation with 50 mM cisplatin reduced mRNA synthesis to about 55% (data not shown). Furthermore, at 25 mM cisplatin we observed increased expression of both p53 and p21
WAF1
. However, when cells were exposed to 50 mM cisplatin for 24 h, p21 WAF1 levels were reduced despite a robust p53 accumulation suggesting that the cisplatin treatment inhibited the transcription of the p21 WAF1 gene. Ionizing radiation was found to only marginally inhibit mRNA synthesis in diploid human ®broblasts and only following very high doses (Figure 1c) . Irradiation with 50 Gy and 100 Gy reduced mRNA synthesis by 3 and 21%, respectively, measured at 5 h Figure 1 Correlation between inhibition of mRNA synthesis and induction of p53 and p21 WAF1 in cells exposed to UV light, cisplatin or ionizing radiation. The eects of the DNA-damaging agents (a) UV light, (b) cisplatin and (c) ionizing radiation on mRNA synthesis (at 5 h) and the cellular levels of p53 and p21 WAF1 (at 24 h) were assessed as described in Materials and methods. The values for mRNA synthesis represents the average of at least two biological experiments with error bars showing the sample standard deviation post-irradiation. When nascent poly(A)RNA synthesis was measured directly (0 ± 30 min) following irradiation with 50 Gy and 100 Gy, we observed inhibition by 13 and 33%, respectively (data not shown) which is in accordance with previously published results (Luchnik et al., 1988; Rodi and Sauerbier, 1989) . Both p53 and p21 WAF1 protein levels were increased 24 h following irradiation with 25 ± 100 Gy. Thus, induction of p53 and p21 WAF1 was dissociated from inhibition of mRNA synthesis following exposure to ionizing radiation. It can be noted that the expression of p21 WAF1 was very high even following exposure to high doses of radiation. These results indicates that neither mRNA synthesis nor expression of the p21 WAF1 gene were signi®cantly inhibited by ionizing radiation.
RNA synthesis inhibitors induce p53
Our studies exploring the eect of UV light and cisplatin on mRNA synthesis and p53 induction suggested that blockage of RNA polymerase II at DNA lesions may be the trigger for the accumulation and activation of p53. To test whether blockage of RNA polymerase II may be sucient for the triggering of p53 accumulation, we chose four dierent agents which are known to inhibit RNA synthesis by dierent mechanisms and monitored their ability to induce p53 and p21
WAF1
. The agents used were actinomycin D, 5,6-dichloro-1-b-D-ribofuranosylbenzimidazole (DRB), 1-(5-isoquinolinylsulfonyl)-3-methylpiperazine (H7) and a-amanitin.
Actinomycin D intercalates DNA and blocks the elongation of RNA polymerases (Sobell, 1985) as well as interferes with DNA topoisomerase I and II (Chen and Liu, 1994; Fergusson and Baguley, 1994) . Actinomycin D has been shown to induce p53 (Kastan et al., 1991) but it is not clear whether this induction is related to its eect on RNA synthesis or its DNAdamaging activity. In accordance with previous studies (Perry and Kelley, 1970) , poly(A)RNA (full length mRNA) synthesis was found to be inhibited by actinomycin D in a dose dependent manner ( Figure  2a ). The induction of p53 protein accumulation was pronounced 24 h following addition of actinomycin D at concentrations of 20 nM or above at which mRNA synthesis was repressed by more than 50%. Expression of the Cdk inhibitor p21 WAF1 was also induced by actinomycin D. However, an enhanced level of p21 WAF1 proteins was observed already at 2 nM of the drug at which no accumulation of the p53 protein was evident. At 200 nM concentrations of the drug, p21 WAF1 protein levels were inhibited to below baseline levels despite high levels of p53 protein expression. This abolishment of p21 WAF1 expression most likely was caused by the severe inhibition of mRNA synthesis at this dose.
We next investigated the eect of the protein kinase inhibitor DRB on mRNA synthesis and its ability to induce p53 and p21
. DRB is thought to inhibit transcription at the level of initiation (Egyhazi, 1976; Ljungman and Hanawalt, 1995; Sehgal et al., 1976) and/or elongation (Chodosh et al., 1989; Giardina and Lis, 1993) . The transcription inhibitory eects of DRB may be related to interference with the activities of casein kinase II (Zandomeni et al., 1986) , the CTD kinase associated with the transcription factor TFIIH (Dubois et al., 1994; Yankulov et al., 1995) , WAF1 expression were performed as described in Materials and methods. The values for mRNA synthesis represent the average of at least two biological experiments with error bars showing the sample standard deviation modulation of chromatin structure of promoter regions (Ljungman, 1996) or stimulation of the negative elongation factor DISF (Wada et al., 1998) . We found that DRB inhibited poly(A)RNA synthesis in a dose dependent manner in human diploid ®broblasts ( Figure  2b ). Induction of p53 occurred at or above 40 mM at which mRNA synthesis was inhibited to more than 50%. Interestingly, there was a discordance between p21 WAF1 and p53 expression in the ®broblast cells in response to DRB. At lower doses, p21 WAF1 protein levels were elevated without concomitant induction of p53. At higher doses (80 mM) at which mRNA synthesis was reduced by more than 60%, the level of p53 was further elevated while p21 WAF1 levels decreased. The isoquinoline derivative H7 does, like DRB, inhibit the CTD kinase (Dubois et al., 1994) . H7 is also known to inhibit other protein kinases such as protein kinase C (PKC) (Hidaka et al., 1984) . Here we show that H7 inhibits poly(A)RNA in a dose dependent manner in normal human ®broblasts (Figure 2c ). Induction of p53 protein accumulation was detected at and above 50 mM H7 at which mRNA synthesis was depressed to about 30% of control cells. Similarly to the other RNA synthesis inhibitors, there was a discordance between the induction of p21 WAF1 and p53 following treatment with H7. Elevated levels of p21 WAF1 was observed already at 25 mM concentrations at which no induction of p53 occurred. At 100 mM of H7 resulting in mRNA synthesis inhibition of more than 70%, the level of p21 WAF1 was found to be substantially below the baseline level of untreated cells while in contrast, the p53 protein level was elevated further.
a-amanitin is known to speci®cally inactivate and target the RNA polymerase II largest subunit for rapid degradation (Nguyen et al., 1996) . At high doses of aamanitin, p53 levels have been shown to increase in human ®broblasts (Andera and Wasylyk, 1997; Yamaizumi and Sugano, 1994) . However, whether the accumulation of p53 following exposure to a-amanitin correlated to inhibition of mRNA synthesis was not established. Since a-amanitin does not readily enter intact cells (Kuwano and Ikehara, 1973) , we measured mRNA synthesis 24 h following addition of the drug. At this time point we observed a substantial degradation of the RNA polymerase II at and above doses of 2 mg/ml (data not shown) as has previously been reported (Nguyen et al., 1996) . Treatment of human ®broblasts for 24 h with a-amanitin resulted in a signi®cant accumulation of p53 at and above doses of 2 mg/ml (Figure 2d) . A slight induction of p53 and p21 WAF1 was observed following exposure to 0.5 mg/ml of a-amanitin at which mRNA synthesis was only moderately aected. A much stronger induction of p53 protein levels were observed at 2 and 10 mg/ml of aamanitin which correlated with a reduction of mRNA synthesis of more than 80%. Finally, we observed an accumulation of p21 WAF1 proteins in cells incubated with 0.5 mg/ml a-amanitin, while at higher doses, the level of p21 WAF1 did not increase despite presence of high levels of p53 in the cells.
Inhibition of the proteasome induces p53 by`default'
The p53 protein is under normal conditions actively degraded by the ubiquitin-dependent proteolysis pathway involving the 26S proteasome (Chowdary et al., 1994; Maki et al., 1996; Schener et al., 1990) and possibly by calpains (Gonen et al., 1997; Kubbutat and Vousden, 1997; Pariat et al., 1997) . These reports have shown that p53 accumulates in cells when the proteasome or calpains are poisoned by speci®c inhibitors or in cells defective in the ubiquitin pathway.
We explored whether the induction of p53 and p21 WAF1 in primary human ®broblast by the proteasome and calpain I inhibitor LLnL correlated with inhibition of mRNA synthesis. The results show that LLnL had no signi®cant eect on poly(A)RNA synthesis in these cells (Figure 3) . However, p53 and p21 WAF1 were induced to high levels when cells had been treated for 24 h with 10 ± 50 mM of LLnL. It is not clear from these experiments whether the induction of p21 WAF1 by LLnL was p53-dependent since the p21 WAF1 protein may normally be regulated by the ubiquitin-dependent proteolysis pathway involving the 26S proteasome (Maki and Howley, 1997) . Thus, p21 WAF1 proteins may accumulate by default in cells when degradation is inhibited and not by transactivation by p53 (Maki et al., 1996) . We conclude that LLnL induces p53 and p21 WAF1 in these cells without aecting mRNA synthesis.
RNA synthesis inhibitors induce p53 without concomitant induction of DNA strand breaks
Since it has been suggested that DNA strand breaks are the DNA template alterations that trigger the p53-dependent DNA damage response pathway (Nelson and Tishler et al., 1993) , we wanted to explore whether the p53-inducing agents used in this study would cause the induction of DNA strand breaks. We chose to use the alkaline unwinding technique to measure DNA strand breaks because this technique is very sensitive and gives reproducible results (AhnstroÈ m and Erixon, 1981) . To avoid measuring DNA strand breaks that may originate Figure 3 Correlation between the inhibition of poly(A)RNA synthesis (5 h), and p53 and p21 WAF1 accumulation (24 h) in human diploid ®broblasts exposed to the proteasome and calpain I inhibitor LLnL. Determination of nascent RNA synthesis, and p53 and p21 WAF1 expression were performed as described in Materials and methods. The values for mRNA synthesis represents the average of at least two biological experiments with error bars showing the sample standard deviation from apoptotic DNA fragmentation, we chose to measure DNA strand breaks at 5 h after adding the drugs. Doses were picked at which strong induction of p53 accumulation was observed following 5 h of incubation (Figure 4a) .
It was found, using the alkaline unwinding technique, that of the RNA synthesis inhibitors used, only the highest dose of actinomycin D treatment (200 nM) resulted in a slight induction of DNA strand breaks (Figure 4b ). However, no signi®cant induction of DNA strand breaks was detected in cells treated with 20 nM of actinomycin D although at this dose a high level of p53 was induced (Figure 4a) . It has been shown that actinomycin D can interfere with DNA topoisomerases (Chen and Liu, 1994; Fergusson and Baguley, 1994) and it was therefore not unexpected that high doses of actinomycin D (200 nM) could result in DNA strand breaks. However, the level of strand breaks induced in the diploid normal human fibroblasts by high doses of actinomycin D was much lower than that induced by 50 mM cisplatin despite similar induction of p53. Since cisplatin-induced DNA lesions are subject to nucleotide excision repair, the high level of strand breaks detected in cisplatin-treated cells may have been caused by repair-mediated DNA incision. To test this we measured DNA strand breaks in nucleotide excision repair-de®cient XP-A cells following 5 h of cisplatin treatment. It was found that cisplatin treatment did not lead to the induction of DNA strand breaks in XP-A cells (Figure 4b) , con®rming that the breaks observed in normal cells treated with cisplatin were linked to incision by DNA repair processes. Finally, no DNA strand breaks were observed in cells treated with the proteasome/calpain I inhibitor LLnL.
Cisplatin induces p53 at lower doses in XP-A cells than in normal cells
To distinguish between the possibilities that cisplatin may induce p53 through DNA repair-induced DNA strand breaks or through some other mechanism such as inhibition of RNA polymerase II elongation, we analysed the induction of p53 in cisplatin treated XP-A cells. If cisplatin induces p53 through repair-induced DNA strand breaks or any other DNA repair intermediate, then we would not expect cisplatin to induce p53 in XP-A cells. As can be seen in Figure 5 , cisplatin treatment resulted in induction of both p53 and p21 WAF1 accumulation in the diploid XP-A ®broblasts. In fact, p53 and p21 WAF1 were induced at signi®cantly lower doses in XP-A cells than in normal human ®broblasts. Thus, in agreement with previous studies for UV light (Ljungman and Zhang, 1996; Yamaizumi and Sugano, 1994) , p53 was induced at lower doses of cisplatin in cells de®cient in nucleotide excision repair. These results suggest that accumulation and activation of p53 was induced in a DNA-repair and DNA strand break-independent manner following exposure to UV light or cisplatin.
Correlations between mRNA synthesis, p53 and the induction of apoptosis
In our previous study (Ljungman and Zhang, 1996) , we found a strong correlation between inhibition of mRNA synthesis, p53 accumulation and the induction of apoptosis following UV-irradiation. To test whether the agents used in this study would show a similar correlation, cells were treated with the dierent agents and the amount of cells undergoing apoptosis 72 h Figure 4 Signi®cant induction of DNA strand breaks by cisplatin but little or no induction of breaks by the RNA synthesis and proteasome inhibitors in normal ®broblasts at doses that induce p53 accumulation. (a) Diploid human ®broblasts were drug-treated for 5 h before the cellular levels of p53 and p21
WAF1
were assessed using Western blot. (b) Diploid human ®broblast were incubated with 50 mM cisplatin, 20 or 200 nM actinomycin D, 40 mM DRB, 50 mM H7, 10 mg/ml a-amanitin or 30 mM LLnL for 5 h after which the induced levels of strand breaks were assessed using the alkaline unwinding technique as described in Materials and methods. In sharp contrast to normal ®broblasts, diploid XP-A ®broblasts incubated with 50 mM cisplatin for 5 h did not induce any DNA strand breaks above the level found in untreated XP-A cells. Each value represent the mean of at least three dierent biological samples with bars showing the sample standard deviation WAF1 accumulation at lower doses of cisplatin than normal ®broblasts (see Figure 1b) . Diploid XP-A ®broblasts were incubated with dierent concentrations of cisplatin for 24 h before p53 and p21 WAF1 levels were assessed using Western blot Blocked RNA polymerase II as a trigger for p53 M Ljungman et al later was assessed using a DNA fragmentation assay as previously described (Chung et al., 1998; Ljungman and Zhang, 1996) .
It was found that all agents that caused inhibition of mRNA synthesis also underwent apoptosis (Table 1) . Furthermore, the doses required to induce apoptosis correlated to the doses needed to cause signi®cant inhibition of mRNA synthesis and to induce the accumulation of p53 (Table 1) . High doses of ionizing radiation did not signi®cantly aect mRNA synthesis. Furthermore, ionizing radiation did not cause cells to undergo apoptosis despite accumulation of active p53. The proteasome inhibitor LLnL did not aect mRNA synthesis but in contrast to ionizing radiation, LLnL treatment induced a signi®cant number of cells to undergo apoptosis as has been previously reported using other cell lines (Drexler, 1997; Shinohara et al., 1996) . We conclude that all agents that inhibited mRNA synthesis induced both p53 accumulation and apoptosis at a similar dose range. However, ionizing radiation did not induce human ®broblasts to undergo apoptosis although irradiated cells induced the accumulation and activation of p53. On the other hand, the proteasome inhibitor LLnL induced apoptosis despite the lack of aect on mRNA synthesis (Table  1) . Thus, inhibition of mRNA synthesis appears to be sucient, but not ultimately required, for the induction of p53 and apoptosis in human diploid ®broblasts.
Discussion
We and others have previously reported on the possible link between blocked transcription and induction of p53, p53-regulated gene products and apoptosis in human cells following exposure to UV light (Ljungman and Zhang, 1996; McKay et al., 1998; Yamaizumi and Sugano, 1994 ). Here we further investigated the connection between blocked RNA polymerase II and the induction of p53 following DNA damage. We found a correlation between inhibition of mRNA synthesis and induction of p53 following exposure to both UV light and cisplatin (Figure 1 ). In contrast, ionizing radiation was found to be a relatively poor inhibitor of mRNA synthesis in human ®broblasts (Figure 1) . Doses above 50 Gy were required to aect mRNA synthesis in mammalian cells which is in agreement with previous studies (Luchnik et al., 1988; Rodi and Sauerbier, 1989) . The enhanced expression of p21 WAF1 following irradiation with 100 Gy further suggest that transcription was not greatly aected by ionizing radiation. The rather modest eect of ionizing radiation compared to UV light on mRNA synthesis is most likely due to the relatively low number of DNA lesions produced by ionizing radiation compared to UV light at an equitoxic dose (Ward, 1988) . Furthermore, human ®broblasts were found to be resistant to radiation-induced apoptosis. Even doses as high as 100 Gy did not result in any signi®cant apoptosis measured at 72 h following irradiation (Table 1) . We conclude that the induction of p53 by ionizing radiation, which occurs at doses as low as 2 ± 5 Gy (Kastan et al., 1991, Figure 4a ), did not appear to be triggered by blockage of RNA polymerase II. Furthermore, radiation-induced accumulation of p53 did not result in apoptosis in primary human ®broblasts.
As p53 accumulation and activation following exposure to UV light or cisplatin correlated to inhibition of mRNA synthesis, we hypothesized that p53 induction was linked to blockage of RNA polymerase II. To explore whether inhibition of RNA polymerase II was sucient for the triggering of p53, we used agents known to interfere with mRNA synthesis and asked if these agents would induce the p53 response. It was found that exposure of cells to either actinomycin D, DRB, H7 or a-amanitin resulted in a marked induction of p53. Moreover, the dose required for induction of p53 correlated with the dose required to inhibit mRNA synthesis. Although these agents are known to exhibit a variety of inhibitory activities aecting multiple cellular functions, the fact that p53 induction occurred at doses at which these agents attenuated mRNA synthesis strongly suggest that the induction of p53 was linked to inhibition of RNA polymerase II. Furthermore, all these drugs induced the cells to undergo apoptosis at doses inhibiting mRNA synthesis. These results support recent studies showing that interference of transcription potentiates the induction of apoptosis in both transformed (Koumenis and Giaccia, 1997) and normal human cells (Andera and Wasylyk, 1997) .
Induction of DNA strand breaks has been suggested to play an important role in DNA damage-induced activation of the p53 response (Nelson and Tishler et al., 1993) . However, DRB, H7, aamanitin and LLnL were in this study found to induce p53 in human ®broblasts without causing any detectable increase in the level of DNA strand breaks (Figure 4) . Treatment of cells with 20 or 200 nM actinomycin D resulted in p53 accumulation but only the higher dose induced detectable DNA strand breaks. Furthermore, repair-mediated DNA strand breaks were detected in cisplatin-treated normal but not in repair-de®cient XP-A cells, yet cisplatin induced p53 in XP-A cells and this induction occurred at lower doses ( Figure 5 ). Although we cannot rule out that these agents did not induce any strand breaks, the extent of p53 accumulation did not correlate to the extent of DNA strand break induction. It could be argued that the induction of p53 by some of the agents used may have been triggered by inhibition of certain protein kinases. For example, in addition to inhibition of cellular CTD kinase activity, DRB and H7 are known Apoptosis was measured as DNA fragmentation as described in Materials and methods. Data for inhibition of mRNA synthesis and p53 induction was taken from Figures 1 ± 3. Doses used for assessing apoptosis were the same as were used in Figures 1 ± 3 and the values presented are derived from at least two dierent experiments to inhibit casein kinase II and protein kinase C, respectively. Although these kinases have been shown to promote p53 phosphorylation in vitro, whether such phosphorylation events aect the function of p53 or even occur in cells has not been fully established (Steegenga et al., 1996) . Importantly, the EC 50 for PKC is 6 mM for H7 (Jarvis et al., 1994 ), yet p53 induction ( Figure 2c ) and induction of apoptosis (Jarvis et al., 1994 , Table 1 ) did not occur until doses at or above 50 mM were used. Furthermore, casein kinase II phosphorylation of p53 is thought to activate p53 (Hupp et al., 1992) and thus, inhibition of casein kinase II by DRB would be expected to block, not enhance, induction of p53. Taken together, DNA strand break-induction, nor inhibition of PKC and casein kinase II, correlated with induction of the p53 response following exposure to these agents. Rather, the results are compatible with a model in which blockage or inhibition of RNA polymerase II by these agents promotes p53 induction. That p53 induction by dierent agents may have dierent molecular triggers and that the triggering signals may be sent through dierent pathways has been suggested from studies involving cells derived from patients with ataxia telangiectasia (AT) and Nijmegen breakage syndrome (NBS). Induction of p53 following ionizing radiation is de®cient in AT and NBS cells while induction of p53 following UV light or MMS treatment is not (Canman et al., 1994; Jongmans et al., 1997; Kastan et al., 1992; Khanna and Lavin, 1993; Lu and Lane, 1993) . Thus, it is believed that the ATM and the NBS gene products are mediators of a signal transduction pathway leading to the induction of p53 following ionizing radiation but not following exposure to UV light. Furthermore, modi®cations (Lu et al., 1998) , stabilization (Maki and Howley, 1997) and the kinetics of induction (Lu and Lane, 1993) of p53 following exposure to UV light or ionizing radiation appear to dier. The results from our study lends further support to the hypothesis that the triggering mechanisms for the induction of the p53 response, and the pathways mediating the activation signal, may be dierent depending on the nature of the inducing agent ( Figure 6 ). We propose that agents that poison the RNA polymerase II or cause transcriptionblocking DNA lesions will signal p53 through a pathway involving blocked RNA polymerase II. Furthermore, p53 can be induced by strand-breaking agents through a pathway that may involve both the ATM and NBS gene products. A third pathway leading to the accumulation, but perhaps not the activation of the p53 protein, is induced by agents interfering with the proteasome-dependent degradation pathway ( Figure 6 ).
The cellular level of the p21 WAF1 protein can under certain circumstances be increased independently of functional p53 (Loignon et al., 1997; Macleod et al., 1995; Zeng and Eldeiry, 1996) . However, p53 induction appears to magnify p21 WAF1 protein expression (Zhan et al., 1996) and thus, p21 WAF1 protein accumulation is commonly used as an indicator of p53 activity. We found that all agents that induced p53 accumulation also caused an increased cellular level of the p21 WAF1 protein. However, for many of the agents tested, the accumulation of p21 WAF1 protein was observed at lower doses than was required to detect an increase in p53 protein levels. This induction of p21 WAF1 protein either represents a p53-independent event or may be dependent on cellular p53 proteins that become activated at these doses without detectable protein accumulation (Hupp et al., 1995) . In addition to the discordant expression of p53 and p21 WAF1 proteins at lower doses, many of the agents caused inhibition of p21 WAF1 protein expression at higher doses. In contrast, p53 protein levels continued to accumulate as a function of dose. Presumably, these results re¯ect the mechanisms by which these proteins are regulated. While induction of p21 WAF1 protein accumulation depends on new transcription, increased p53 protein levels are thought to be regulated at the level of protein stability rather than at the level of transcription (Maltzman and Czyzyk, 1984) . Therefore, inhibition of transcription would impede p21 WAF1 expression as suggested following UV light exposure (McKay et al., 1998) . Alternatively, the attenuated expression of p21 WAF1 at high doses of the RNA synthesis inhibitors may be due to caspase-mediated cleavage of the p21 WAF1 protein (Levkau et al., 1998; Poon and Hunter, 1998) .
If inhibition of RNA polymerase gives rise to a signal that results in the induction of p53 and apoptosis, what are the molecular components that link the transcription machinery to p53? Is it the RNA polymerase II itself and/or associated factors sensing the blocked RNA polymerase leading to a signal inducing p53? Or could the induction of p53 stem from inhibition of the expression of a short-lived protein involved in p53 protein degradation and/or apoptosis regulation? Future studies will focus on the identification of potential components of the signal transduction pathway that link blocked RNA polymerase II to the p53 and apoptotic pathways. Furthermore, eorts a Figure 6 Model of p53 induction by three dierent pathways. First, blockage of RNA polymerase II appears to be sucient for the induction of p53 in normal ®broblasts. RNA polymerase II inhibitors such as actinomycin D, DRB, H7 and a-amanitin or DNA-damaging agents such as UV light or cisplatin induce p53 at doses which interfere with the function of RNA polymerase II. Secondly, the p53 response can be triggered by DNA strand breaks without the requirement of RNA polymerase II inhibition following exposure to ionizing radiation. This pathway may involve the ATM and NBS gene products. Thirdly, inhibition of the proteasome/calpain I-dependent degradation of p53 by LLnL triggers p53 accumulation by`default' directed toward the exploration of RNA polymerase II inhibitors for cancer therapy may be warranted since these agents are expected to trigger apoptosis without the risk of inducing mutations in surviving cells.
Materials and methods

Cell culture, chemicals and irradiation
Normal neonatal human diploid ®broblasts (a gift from Dr Mary Davis, University of Michigan), were grown as monolayers in MEM supplemented with 10% fetal calf serum, 16vitamins, 16amino acids and 16antibiotics. Subcon¯uent cells, seeded 2 days prior to the experiments, were irradiated on ice with ionizing radiation (cobalt source with a dose rate of about 2 Gy/min), or were irradiated at room temperature with a germicidal UV light (254 nm). The¯uence of the UV light source (Philips) was measured prior to each experiment with a UVX radiometer (UVP, Inc.). All the chemicals used were purchased from Sigma. Stock solutions were prepared in the following concentrations: actinomycin D, 1 mM in DMSO; DRB (5,6-dichloro-1-b-D-ribofuranosylbenzimidazole), 50 mM in ethanol; H7 (1-(5-isoquinolinylsulfonyl)-3-methylpiperazine), 5 mM in water; cisplatin, 10 mM in water; LLnL (N-acetyl-L-leucinyl-L-leucinal-L-norleucinal), 100 mM in DMSO.
Measurements of nascent mRNA synthesis
Cells were labeled with 185 Bq/ml [ 14 C]thymidine for 2 days prior to the experiments. Cells were then irradiated or started on drug treatment. Following incubation for 4.5 h, nascent RNA was pulse-labeled in 0.5 ml media containing 7.4610 5 Bq (20 mCi) of [ 3 H]uridine for 30 min at 378C in the presence of the drugs. The cells were then put on ice, washed three times with ice-cold PBS and scraped o the plates with a rubber policeman. Poly(A)mRNA was isolated from cell lysates using the Straight A's mRNA isolation system (Novagen) and 3 H activity was counted in a scintillation counter.
Total nascent RNA synthesis was measured by precipitating the RNA that did not bind to the poly(dT) magnetic beads with an equal volume of 10% ice cold TCA. The RNA was precipitated on ice for 30 min and the TCA insoluble material was collected on ®lters (GF/A, Whatman). The ®lters were washed with 561 ml of 5% TCA, 561 ml dH 2 O and 261 ml of 95% ethanol and then dried for 10 min under a heating lamp. The dried ®lters were then put in scintillation vials together with 5 ml of scintillation liquid (UniverSol, ICN) and the samples were counted using a dual program recording 3 H and 14 C activity in separate windows. Relative total RNA synthesis and poly(A)RNA synthesis was then determined by calculating the ratio of 3 H/ 14 C for each sample and comparing it with the ratio from an untreated control sample.
Western blotting
Collection and lysis of cells and SDS ± PAGE was performed as previously described (Chung et al., 1998; Ljungman and Zhang, 1996) . The antibodies used included three dierent batches of p53 (Ab-2) and one batch of p21 WAF1 (Oncogene Sciences). The amounts of antibodies bound were detected using enhanced chemiluminescence (SuperSignal CL-HRP Substrate System, Pierce) and X-ray ®lm. Autorads were scanned on a¯atbed scanner (Mirror or Apple) and the data analysed using NIH Image analysis software. To assess whether equal amounts of protein were loaded in each lane, the nylon membranes were stained with Coomassie blue following the completion of the ®lm exposure.
Measurement of DNA strand breaks
Cells, pre-labeled for 48 h with 500 Bq/ml of [ 14 C]thymidine, were treated with various drugs for 5 h before induced strand breaks were measured using the alkaline unwinding technique as previously described (AhnstroÈ m and Erixon, 1981) . Drug-treated 24-well culture dishes were rinsed with 0.15 M NaCl and then 0.5 ml ice-cold 0.03 M NaOH, 0.15 M NaCl solution was added to each well and the DNA was allowed to unwind for 30 min in the dark at 48C. After neutralization with 0.5 ml 0.04 M NaH 2 PO 4 solution, the samples were sonicated for 10 s (Branson soni®er, output level 3) followed by addition of 1 ml 0.5% SDS after which the samples were frozen. Single-stranded DNA was eluted from hydroxylapatite columns (HTP, BioRad) by 0.13 M phosphate buer (pH 6.8) while doubled-stranded DNA was subsequently eluted by 0.25 M phosphate buer. The number of strand breaks induced per 10 9 daltons of DNA were determined by the formula: SSB/10 9 daltons = k InF ds . (Ahnstro È m and Erixon, 1981) . The value of k for these unwinding conditions was 730 (Erixon and AhnstroÈ m, 1979) .
Apoptosis
Apoptosis-induced DNA degradation was examined using a recently developed assay involving direct lysis of cells in the wells of agarose gels followed by conventional gel electrophoresis as previously described (Chung et al., 1998; Ljungman and Zhang, 1996) . Two biological samples were analysed for each dose.
